Volume 15, Number 9—September 2009
Role of Rhinovirus C in Apparently Life-Threatening Events in Infants, Spain
To assess whether infants hospitalized after an apparently life-threatening event had an associated respiratory virus infection, we analyzed nasopharyngeal aspirates from 16 patients. Nine of 11 infants with positive virus results were infected by rhinoviruses. We detected the new genogroup of rhinovirus C in 6 aspirates.
Human rhinovirus (HRV) is 1 of the most common agents associated with upper and lower respiratory tract infections in children and infants (1) and is a major trigger of asthma exacerbations (2). Recently, molecular methods have shown substantial phenotypic variation of HRV and identified a novel HRV genogroup provisionally named HRV-C (3). Severe asthma exacerbations in children have been associated with this new genogroup of rhinoviruses. Genogroup C could be resistant to a new candidate group of antipicornavirus drugs, including pleconaril (4).
Apparently life-threatening events (ALTEs) in infants are associated with bronchiolitis or infections in up to 6% of patients by diagnosis after hospital admission (5). We assessed the relation between ALTEs and respiratory virus infection in a secondary hospital in Spain.
Our study was part of a systematic prospective study to assess the epidemiology of respiratory virus infections in children admitted to the Severo Ochoa Hospital (Leganés, Madrid Province, Spain).We conducted a specific study to determine the incidence of respiratory virus infections in all infants admitted after ALTEs during November 2004–December 2008. An ALTE in a child <1 year of age was defined as an episode that is frightening to the observer and characterized by some combination of apnea, color change, marked change in muscle tone, choking, or gagging so the observer fears the infant has died (6).
Nasopharyngeal aspirate (NPA) specimens were acquired from each eligible patient at the time of hospital admission (on Monday–Friday). Samples were sent for virologic study to the Influenza and Respiratory Virus Laboratory (National Centre for Microbiology, Institute of Health Carlos III, Spain). Specimens were processed within 24 hours after collection.
Total nucleic acids were extracted from 200-µL aliquots by using a QIAamp MinElute Virus Spin Kit in a QIAcube automated extractor (QIAGEN, Valencia, CA, USA). Simple or multiplex reverse transcription–nested PCR assays (RT-PCR) previously described (7–9) were used to assess the virus diagnosis, including 16 respiratory viruses or groups of viruses. Degenerated primers for HRV and enteroviruses were designed between the 3′ end of the 5′ noncoding region (NCR) and the viral protein (VP) 4/VP2 polyprotein gene (TCIGGIARYTTCCASYACCAICC-3′ and CTGTGTTGAWACYTGAGCICCCA-3′). HRVs from positive samples were identified by sequencing and phylogenetic analysis of these sequences. Amplified products (about 500 bp, depending on HRV serotype) were purified and sequenced in both directions by using an automated ABI PRISM 377 model sequencer. Partial sequences of HRV have been submitted to GenBank (accession nos. FJ841954–FJ841957, FJ841959–FJ841961, EU697826, and EU697832). Appropriate precautions were implemented to avoid false-positive results by carryover contamination. Positive results were confirmed by testing a second aliquot of the sample stored at –70ºC.
Sixteen infants (8 of each sex) were enrolled in the study. All patients were <5 months of age (range 7 days–5 months, mean age 7.6 weeks, median 4 weeks). Twelve infants had rhinorrea, cough, and distress signs (Table). A total of 11 (69%) NPA specimens were positive for at least 1 viral agent. For 9 of these patients, positive results for HRV were confirmed, and for the other 2 patients, respiratory syncytial virus was detected.
Phylogenetic analyses of 9 sequences obtained from patients showed distribution of HRV in 3 clusters. Three sequences were included in previously characterized clades, defined by HRV group A (HRV-A, SO4923–EU697826) and B (HRV-B, SO3970–FJ841954 and SO4998–EU697832). Sequence from patient SO4923 had a low sequence similarity with the other serotypes of HRV-A. In contrast, sequences from patients SO3970 and SO4998 were closely related to HRV-35 and HRV-79, respectively. Six sequences were included in the third group corresponding to the new HRV-C: SO5854, SO6666, SO5797, SO6819, SO5986, SO6813- FJ841955-57 and FJ841959-61) (3,10) (Figure). Different genotypes (collectively called HRV-Cs) were identified in 6 NPA specimens from children with ALTEs (67% of total HRV). Two received cardiopulmonary resuscitation at home; for these 2 patients, a respiratory syncytial virus and an HRV-C were identified. All 16 children survived.
The most common discharge diagnoses reported for ALTEs are gastroesophageal reflux disease (GERD), unknown causes, seizures, and lower respiratory tract infections (11). Our series suggests that ALTEs of previously unknown etiology could be related to HRV infections. Rhinovirus infections are known to be a major cause of illness and hospital admission for young children, particularly infants <2 years of age (12). Detection of viral genomes by nested RT-PCR in NPA specimens led us to analyze the effect of HRV infections in different clinical situations. Respiratory infections associated with HRV might play a major role in young infants, probably with few clinical signs, and might contribute to apnea as a first manifestation. GERD is the most frequent hospital discharge diagnosis in published series (5,11). For our patients, GERD also was the most frequent clinical diagnosis (9 patients), but for 7 of them, a respiratory virus was identified. We cannot conclude whether GERD is a risk factor for apnea or whether signs are so nonspecific that diagnoses could be confused.
Alternatively, the new HRV-C group could account for as many as a quarter or even half of HRV infections (4,13). In children, it has been associated with bronchiolitis, wheezing, and asthma exacerbations severe enough to require hospitalization; the percentage of these children with hypoxia was substantial (13). In a case–control study, Khetsuriani et al. (4) found HRV-C only in case-patients, supporting the pathogenic role of this genogroup. They considered that HRV-C infections could be associated with more severe clinical manifestations than infections with other HRV genogroups A and B. These data could also support the role of HRV-C in infants with ALTEs found in this work.
Although we had no control group for our patients, we recently published a study of a cohort of 316 newborns up to 6 months of age tested weekly for respiratory diseases (mainly upper respiratory tract infections), coincident in age and time with our patients (14). HRV was present in 5 (3.6%) of 72 infants tested. Two viruses were genetically identified as HRV-C, demonstrating they form distinct genetic clusters, and no genetic similarity was obtained with the ALTE–related HRV-C viruses. In addition, a second group of asymptomatic children of different ages but in coincident epidemic seasons was studied. The group of children with HRV was substantially smaller than the group of children with respiratory disease (15).
Viral infections could play a major role in ALTEs. Rhinoviruses, especially HRV-C, could cause a respiratory infection with few symptoms in young infants and could trigger ALTEs in this age group. Therefore, HRVs and posterior genotyping should be included in studies of the etiology of ALTEs to help identify the true relevance of HRV-C infection to these episodes.
Dr Calvo is chief clinician of pediatrics at Hospital Severo Ochoa, Leganés, Madrid, Spain. Her research interests include infectious diseases in children.
We thank Lola Lopez-Valero, Nieves Cruz, Monica Sánchez, and Ana Calderón for technical assistance.
This work was supported by grant PI060532 by Fondo de Investigaciones Sanitarias, Institute of Health Carlos III. Research on viral respiratory infections is carried out in collaboration with the Influenza and Respiratory Viruses Laboratory at the National Center of Microbiology (ISCIII) and supported by the Health Research Fund.
- Kusel MMH, Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly P. Role of respiratory viruses in upper and lower respiratory tract illness in the first year of life. A birth cohort study. Pediatr Infect Dis J. 2006;25:680–6.
- Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116:571–7.
- Lamson D, Renwick N, Kapoor V, Liu Z, Palacios G, Ju J, MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004–2005. J Infect Dis. 2006;194:1398–402.
- Khetsuriani N, Lu X, Teague WG, Kazerouni N, Aderson LJ, Erdman DD. Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis. 2008;14:1793–6.
- Bonkowsky JL, Guenther E, Filloux FM, Srivastava R. Death, child abuse and adverse neurological outcome of infants after apparent life-threatening event. Pediatrics. 2008;122:125–31.
- National Institutes of Health Consensus Development Conference on Infantile Apnea and Home Monitoring, Sep 29 to Oct 1, 1986. Pediatrics. 1987;79:292–9.
- Pozo F, García-García ML, Calvo C, Cuesta I, Pérez-Breña P, Casas I. High incidence of human bocavirus infection in children in Spain. J Clin Virol. 2007;40:224–8.
- Coiras MT, Aguilar JC, Garcia ML, Casas I, Perez-Brena P. Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays. J Med Virol. 2004;72:484-95.
- López-Huertas MR, Casas I, Acosta-Herrera B, Garcia ML, Coiras MT, Pérez-Breña P. Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates. J Virol Methods. 2005;129:1–7.
- Briese T, Renwick N, van den Berg M, Jarman R, Ghosh D, Köndgen S, Role of rhinovirus in hospitalized infants with respiratory tract infections in Spain. Emerg Infect Dis. 2008;14:944–7.
- McGovern MC, Smith MB. Causes of apparent life threatening events in infants: a systematic review. Arch Dis Child. 2004;89:1043–8.
- Calvo C, García-García ML, Blanco C, Pozo F, Casas I, Perez-Breña P. Rhole of rhinovirus in hospitalized infants with respiratory tract disease in Spain. Pediatr Infect Dis J. 2007;26:904–8.
- Miller EK, Edwards KM, Weinberg GA, Iwane MK, Griffin MR, Hall CB, A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol. 2009;123:105–6.
- Bueno Campaña M, Calvo Rey C, Vázquez Alvarez MC, Parra Cuadrado E, Molina Amores A, Rodrigo García G, Infecciones virales de vías respiratorias en los primeros 6 meses de vida. An Pediatr (Barc). 2008;69:400–5.
- García-García ML, Calvo C, Pozo F, Pérez-Breña P, Quevedo S, Bracamonte T, Human bocavirus detection in nasopharyngeal aspirates of children without clinical symptoms of respiratory infection. Pediatr Infect Dis J. 2008;27:358–60.
- Figure. Phylogenetic analysis of 5′ noncoding region and viral protein (VP) 4/2 coding region of 9 human rhinoviruses (HRVs) identified in infants with apparently life-threatening events in Spain, November 2004–December 2008....
Suggested citation for this article: Calvo C, García ML, Pozo F, Reyes N, Pérez-Breña P, Casas I. Role of rhinovirus C in apparently life-threatening events in infants, Spain. Emerg Infect Dis [serial on the Internet]. 2009 Sep [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/9/09-0453
Please use the form below to submit correspondence to the authors or contact them at the following address:
Cristina Calvo, Hospital Severo Ochoa, Avda. Orellana, s.n.; 28911 Leganés; Madrid; Spain;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 08, 2010
- Page last updated: December 08, 2010
- Page last reviewed: December 08, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)